Role of the Wnt and GTPase pathways in breast cancer tumorigenesis and treatment

Nasim Ebrahimi; Kamyar Kharazmi; Masoud Ghanaatian; Seyed Ali Miraghel; Yasaman Amiri; Seyede Sanaz Seyedebrahimi; Halimeh Mobarak; Elnaz Yazdani; Sahar Parkhideh; Michael R Hamblin; Amir Reza Aref

doi:10.1016/j.cytogfr.2022.05.001

Related publications

Article2021

HIF-1–regulated expression of calreticulin promotes breast tumorigenesis and progression through Wnt/β-catenin pathway activation

Xiaoxu Liu, Peiling Xie, Na Hao, Miao Zhang, Yang Liu, Peijun Liu, Gregg L. Friedman, Jianjun He, Huimin Zhang

Article2012

The role of PHD2 in breast cancer metastasis

Anna Kuchnio, Stijn Moens, Ulrike Brüning, Karol Kuchnio, Michaël Broux, Andreea Alexandra Ungureanu, Rodrigo Leite-de-Oliveira, Françoise Bruyére, Juan R. Hernández‐Fernaud, Sara Zanivan, Carmen Bartic, Jean-Michael Foidart, Agnès Noël, Stefan Vinckier, Mieke Dewerchin, Max Mazzone, Peter Carmeliet

Article2022

“The emerging role of capivasertib in breast cancer”

Αngeliki Andrikopoulou, Spyridoula Chatzinikolaou, Evangelia Panourgias, Μαρία Καπαρέλου, Michalis Liontos, Meletios A Dimopoulos, Flora Zagouri

Letter2019

Disruption of Long Noncoding RNAs Targets Cancer Hallmark Pathways in Lung Tumorigenesis

Verónica Dávalos, Manel Esteller

Article2024

The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression

Jian Jian Kang, Stefania Gallucci, Jian Pan, Jonathan S. Oakhill, Elaine Sanij